Kanao Serika, Urano Makoto, Fujita Kazuhisa, Utsumi Fumi, Sugihara Kazuhiro, Shibata Kiyosumi
Department of Obstetrics and Gynecology, Fujita Health University Bantane Hospital, Nagoya, Aichi, Japan.
Department of Diagnostic Pathology, Fujita Health University Bantane Hospital, Nagoya, Aichi, Japan.
Fujita Med J. 2025 Feb;11(1):54-58. doi: 10.20407/fmj.2024-017. Epub 2024 Oct 31.
Mesonephric-like adenocarcinoma of the uterine corpus was first reported in 2016, and added as a new item to the 5th edition of the WHO classification in 2020. It accounts for approximately 1% of patients with uterine corpus cancer, being rare. The histology of this carcinoma varies, making pathological diagnosis difficult. A diagnosis is made at an advanced stage in comparison with other histological types of uterine corpus cancer, and the prognosis is reportedly poor with high-level malignancy. In addition, there are few case reports of mesonephric-like adenocarcinoma of the uterine corpus with sarcoma. In this study, we report a patient in whom preoperative chemotherapy was performed under a diagnosis of cervical carcinoma, but the resected specimen led to a diagnosis of sarcomatous component-mixed mesonephric-like adenocarcinoma of the uterine corpus after surgery.
子宫体中肾样腺癌于2016年首次被报道,并于2020年被添加到世界卫生组织分类第5版中作为一个新项目。它约占子宫体癌患者的1%,较为罕见。这种癌的组织学表现多样,使得病理诊断困难。与其他组织学类型的子宫体癌相比,其诊断多在晚期,据报道预后较差,恶性程度高。此外,子宫体中肾样腺癌合并肉瘤的病例报告很少。在本研究中,我们报告了一名患者,该患者术前被诊断为宫颈癌并接受了化疗,但术后切除标本诊断为子宫体肉瘤成分混合的中肾样腺癌。